Mumbai, Aug. 4 -- The approved product is the generic equivalent of IC-Green, marketed by Diagnostic Green LLC. The USFDA has designated the application as a Competitive Generic Therapy (CGT). Eligibility for the 180-day marketing exclusivity available under the CGT pathway will be determined by the USFDA and, where applicable, will commence from the date of first commercial launch.

Indocyanine Green for Injection is an optical imaging agent used for fluorescence imaging of blood vessels, blood flow and tissue perfusion during vascular, gastrointestinal, organ transplant, plastic, micro- and reconstructive surgeries, including minimally invasive procedures. It is also indicated for fluorescence imaging of extrahepatic biliary ducts, lymp...